We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
84 hedge funds and large institutions have $108M invested in Sorrento Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
44% more capital invested
Capital invested by funds: $75M → $108M (+$33.3M)
23% more call options, than puts
Call options by funds: $2.45M | Put options by funds: $1.98M
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
8% more funds holding
Funds holding: 78 → 84 (+6)
Holders
84
Holders Change
+6
Holders Change %
+7.69%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
27
Reduced
22
Closed
12
Calls
$2.45M
Puts
$1.98M
Net Calls
+$466K
Net Calls Change
+$423K
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$10.3M |
| 2 |
Morgan Stanley
New York
|
-$5.39M |
| 3 |
Citigroup
New York
|
-$2.22M |
| 4 |
D.E. Shaw & Co
New York
|
-$2.17M |
| 5 |
Renaissance Technologies
New York
|
-$1.94M |
